1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ophthalmic Devices and Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Ophthalmic Devices
1.2.3 Ophthalmic Drugs
1.3 Market by Application
1.3.1 Global Ophthalmic Devices and Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ophthalmic Devices and Drugs Market Perspective (2018-2029)
2.2 Ophthalmic Devices and Drugs Growth Trends by Region
2.2.1 Global Ophthalmic Devices and Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Ophthalmic Devices and Drugs Historic Market Size by Region (2018-2023)
2.2.3 Ophthalmic Devices and Drugs Forecasted Market Size by Region (2024-2029)
2.3 Ophthalmic Devices and Drugs Market Dynamics
2.3.1 Ophthalmic Devices and Drugs Industry Trends
2.3.2 Ophthalmic Devices and Drugs Market Drivers
2.3.3 Ophthalmic Devices and Drugs Market Challenges
2.3.4 Ophthalmic Devices and Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ophthalmic Devices and Drugs Players by Revenue
3.1.1 Global Top Ophthalmic Devices and Drugs Players by Revenue (2018-2023)
3.1.2 Global Ophthalmic Devices and Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Ophthalmic Devices and Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ophthalmic Devices and Drugs Revenue
3.4 Global Ophthalmic Devices and Drugs Market Concentration Ratio
3.4.1 Global Ophthalmic Devices and Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Devices and Drugs Revenue in 2022
3.5 Ophthalmic Devices and Drugs Key Players Head office and Area Served
3.6 Key Players Ophthalmic Devices and Drugs Product Solution and Service
3.7 Date of Enter into Ophthalmic Devices and Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ophthalmic Devices and Drugs Breakdown Data by Type
4.1 Global Ophthalmic Devices and Drugs Historic Market Size by Type (2018-2023)
4.2 Global Ophthalmic Devices and Drugs Forecasted Market Size by Type (2024-2029)
5 Ophthalmic Devices and Drugs Breakdown Data by Application
5.1 Global Ophthalmic Devices and Drugs Historic Market Size by Application (2018-2023)
5.2 Global Ophthalmic Devices and Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Ophthalmic Devices and Drugs Market Size (2018-2029)
6.2 North America Ophthalmic Devices and Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Ophthalmic Devices and Drugs Market Size by Country (2018-2023)
6.4 North America Ophthalmic Devices and Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ophthalmic Devices and Drugs Market Size (2018-2029)
7.2 Europe Ophthalmic Devices and Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Ophthalmic Devices and Drugs Market Size by Country (2018-2023)
7.4 Europe Ophthalmic Devices and Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ophthalmic Devices and Drugs Market Size (2018-2029)
8.2 Asia-Pacific Ophthalmic Devices and Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ophthalmic Devices and Drugs Market Size (2018-2029)
9.2 Latin America Ophthalmic Devices and Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Ophthalmic Devices and Drugs Market Size by Country (2018-2023)
9.4 Latin America Ophthalmic Devices and Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ophthalmic Devices and Drugs Market Size (2018-2029)
10.2 Middle East & Africa Ophthalmic Devices and Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zeiss
11.1.1 Zeiss Company Detail
11.1.2 Zeiss Business Overview
11.1.3 Zeiss Ophthalmic Devices and Drugs Introduction
11.1.4 Zeiss Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.1.5 Zeiss Recent Development
11.2 Haag Streit
11.2.1 Haag Streit Company Detail
11.2.2 Haag Streit Business Overview
11.2.3 Haag Streit Ophthalmic Devices and Drugs Introduction
11.2.4 Haag Streit Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.2.5 Haag Streit Recent Development
11.3 Topcon
11.3.1 Topcon Company Detail
11.3.2 Topcon Business Overview
11.3.3 Topcon Ophthalmic Devices and Drugs Introduction
11.3.4 Topcon Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.3.5 Topcon Recent Development
11.4 Nidek
11.4.1 Nidek Company Detail
11.4.2 Nidek Business Overview
11.4.3 Nidek Ophthalmic Devices and Drugs Introduction
11.4.4 Nidek Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.4.5 Nidek Recent Development
11.5 Essilor
11.5.1 Essilor Company Detail
11.5.2 Essilor Business Overview
11.5.3 Essilor Ophthalmic Devices and Drugs Introduction
11.5.4 Essilor Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.5.5 Essilor Recent Development
11.6 Ziemer
11.6.1 Ziemer Company Detail
11.6.2 Ziemer Business Overview
11.6.3 Ziemer Ophthalmic Devices and Drugs Introduction
11.6.4 Ziemer Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.6.5 Ziemer Recent Development
11.7 Canon
11.7.1 Canon Company Detail
11.7.2 Canon Business Overview
11.7.3 Canon Ophthalmic Devices and Drugs Introduction
11.7.4 Canon Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.7.5 Canon Recent Development
11.8 Gulden Ophthalmics
11.8.1 Gulden Ophthalmics Company Detail
11.8.2 Gulden Ophthalmics Business Overview
11.8.3 Gulden Ophthalmics Ophthalmic Devices and Drugs Introduction
11.8.4 Gulden Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.8.5 Gulden Ophthalmics Recent Development
11.9 Optovue
11.9.1 Optovue Company Detail
11.9.2 Optovue Business Overview
11.9.3 Optovue Ophthalmic Devices and Drugs Introduction
11.9.4 Optovue Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.9.5 Optovue Recent Development
11.10 Quest Medical
11.10.1 Quest Medical Company Detail
11.10.2 Quest Medical Business Overview
11.10.3 Quest Medical Ophthalmic Devices and Drugs Introduction
11.10.4 Quest Medical Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.10.5 Quest Medical Recent Development
11.11 Phoenix DeVentures
11.11.1 Phoenix DeVentures Company Detail
11.11.2 Phoenix DeVentures Business Overview
11.11.3 Phoenix DeVentures Ophthalmic Devices and Drugs Introduction
11.11.4 Phoenix DeVentures Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.11.5 Phoenix DeVentures Recent Development
11.12 EyeKon Medical
11.12.1 EyeKon Medical Company Detail
11.12.2 EyeKon Medical Business Overview
11.12.3 EyeKon Medical Ophthalmic Devices and Drugs Introduction
11.12.4 EyeKon Medical Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.12.5 EyeKon Medical Recent Development
11.13 FCI Ophthalmics
11.13.1 FCI Ophthalmics Company Detail
11.13.2 FCI Ophthalmics Business Overview
11.13.3 FCI Ophthalmics Ophthalmic Devices and Drugs Introduction
11.13.4 FCI Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.13.5 FCI Ophthalmics Recent Development
11.14 Atrion
11.14.1 Atrion Company Detail
11.14.2 Atrion Business Overview
11.14.3 Atrion Ophthalmic Devices and Drugs Introduction
11.14.4 Atrion Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.14.5 Atrion Recent Development
11.15 Sterimedix
11.15.1 Sterimedix Company Detail
11.15.2 Sterimedix Business Overview
11.15.3 Sterimedix Ophthalmic Devices and Drugs Introduction
11.15.4 Sterimedix Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.15.5 Sterimedix Recent Development
11.16 OPIA
11.16.1 OPIA Company Detail
11.16.2 OPIA Business Overview
11.16.3 OPIA Ophthalmic Devices and Drugs Introduction
11.16.4 OPIA Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.16.5 OPIA Recent Development
11.17 IRIDEX
11.17.1 IRIDEX Company Detail
11.17.2 IRIDEX Business Overview
11.17.3 IRIDEX Ophthalmic Devices and Drugs Introduction
11.17.4 IRIDEX Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.17.5 IRIDEX Recent Development
11.18 Jardon Eye Prosthetics
11.18.1 Jardon Eye Prosthetics Company Detail
11.18.2 Jardon Eye Prosthetics Business Overview
11.18.3 Jardon Eye Prosthetics Ophthalmic Devices and Drugs Introduction
11.18.4 Jardon Eye Prosthetics Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.18.5 Jardon Eye Prosthetics Recent Development
11.19 Santen Pharmaceutical
11.19.1 Santen Pharmaceutical Company Detail
11.19.2 Santen Pharmaceutical Business Overview
11.19.3 Santen Pharmaceutical Ophthalmic Devices and Drugs Introduction
11.19.4 Santen Pharmaceutical Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.19.5 Santen Pharmaceutical Recent Development
11.20 Bausch Health
11.20.1 Bausch Health Company Detail
11.20.2 Bausch Health Business Overview
11.20.3 Bausch Health Ophthalmic Devices and Drugs Introduction
11.20.4 Bausch Health Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.20.5 Bausch Health Recent Development
11.21 Takeda
11.21.1 Takeda Company Detail
11.21.2 Takeda Business Overview
11.21.3 Takeda Ophthalmic Devices and Drugs Introduction
11.21.4 Takeda Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.21.5 Takeda Recent Development
11.22 Novartis
11.22.1 Novartis Company Detail
11.22.2 Novartis Business Overview
11.22.3 Novartis Ophthalmic Devices and Drugs Introduction
11.22.4 Novartis Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.22.5 Novartis Recent Development
11.23 Genentech
11.23.1 Genentech Company Detail
11.23.2 Genentech Business Overview
11.23.3 Genentech Ophthalmic Devices and Drugs Introduction
11.23.4 Genentech Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.23.5 Genentech Recent Development
11.24 Allergan
11.24.1 Allergan Company Detail
11.24.2 Allergan Business Overview
11.24.3 Allergan Ophthalmic Devices and Drugs Introduction
11.24.4 Allergan Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.24.5 Allergan Recent Development
11.25 Sun Pharmaceutical Industries
11.25.1 Sun Pharmaceutical Industries Company Detail
11.25.2 Sun Pharmaceutical Industries Business Overview
11.25.3 Sun Pharmaceutical Industries Ophthalmic Devices and Drugs Introduction
11.25.4 Sun Pharmaceutical Industries Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.25.5 Sun Pharmaceutical Industries Recent Development
11.26 Actavis Generics
11.26.1 Actavis Generics Company Detail
11.26.2 Actavis Generics Business Overview
11.26.3 Actavis Generics Ophthalmic Devices and Drugs Introduction
11.26.4 Actavis Generics Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.26.5 Actavis Generics Recent Development
11.27 Regeneron Pharmaceuticals
11.27.1 Regeneron Pharmaceuticals Company Detail
11.27.2 Regeneron Pharmaceuticals Business Overview
11.27.3 Regeneron Pharmaceuticals Ophthalmic Devices and Drugs Introduction
11.27.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.27.5 Regeneron Pharmaceuticals Recent Development
11.28 Pfizer
11.28.1 Pfizer Company Detail
11.28.2 Pfizer Business Overview
11.28.3 Pfizer Ophthalmic Devices and Drugs Introduction
11.28.4 Pfizer Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.28.5 Pfizer Recent Development
11.29 Johnson and Johnson
11.29.1 Johnson and Johnson Company Detail
11.29.2 Johnson and Johnson Business Overview
11.29.3 Johnson and Johnson Ophthalmic Devices and Drugs Introduction
11.29.4 Johnson and Johnson Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.29.5 Johnson and Johnson Recent Development
11.30 Bausch and Lomb
11.30.1 Bausch and Lomb Company Detail
11.30.2 Bausch and Lomb Business Overview
11.30.3 Bausch and Lomb Ophthalmic Devices and Drugs Introduction
11.30.4 Bausch and Lomb Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.30.5 Bausch and Lomb Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
| ※参考情報 眼科用機器および医薬品は、目の健康および視覚機能を改善するために設計された医療用品や治療薬を指します。これらは眼科診療や治療において重要な役割を担っています。視覚の問題や眼病に対して、専門的な知識と技術が求められる分野でもあります。 眼科用機器は、目の診断、治療、手術を行うためのさまざまな装置や器具を含みます。これには、視力検査や眼科的診断を行うための器具、手術用の機器、眼圧を測定する装置、コンタクトレンズや人工眼球などが含まれます。特に、近年の技術革新により、多くの機器がデジタル化され、より正確な診断や治療が可能になっています。 眼圧測定器は、緑内障など眼圧の異常を検知するために使用されます。眼帯温度計やトノメーターなど複数の種類が存在し、非接触型のものも多く、患者への負担を軽減しています。また、視力検査器具であるオプトタイプやスクリーニング機器は、視力や視野の評価に用いられ、早期に異常を発見する助けとなります。さらに、網膜を直接観察するためのスリットランプや、超音波装置なども重要な役割を果たしています。 治療に関しては、眼科でも多くの医薬品が使用されています。主に、抗生物質、抗炎症薬、緑内障治療薬、アレルギー治療薬などが含まれます。これらの医薬品は、点眼剤として用いられることが一般的です。点眼薬は直接目に投与できるため、治療効果が早く現れ、全身への副作用が少ないのが特徴です。 抗生物質は、感染症の治療において非常に重要で、細菌性結膜炎などの病状に使われます。抗炎症薬は、目の炎症を抑えるために使用され、アレルギー性結膜炎や自己免疫疾患などに対して処方されることがあります。緑内障治療薬は目の圧力を下げ、視神経の損傷を防ぐために用いられます。 眼科用機器や医薬品の進歩はテクノロジーの発展と密接に関連しています。画像診断技術の進展により、例えば、網膜の詳細な画像を取得するためのOCT（光干渉断層計）は、非常に精密な診断を可能にしました。このような技術により、眼科医はより早期に病気を発見し、適切な治療を行うことができるようになっています。 また、最近では人工知能（AI）を活用した診断ツールも注目されています。AIは大量のデータを解析し、病気の早期発見を補助することが期待されています。これにより、患者一人ひとりに対して個別化された医療が可能になると予想されています。 一般的には、眼科用機器や医薬品は、多種多様な病気や障害に対応するために製造されており、常にその技術や成分が進化しています。新薬開発や新しい治療法の研究も積極的に行われており、慢性的な眼病や加齢に伴う視力低下の治療法を改善することが求められます。 眼科分野は労働集約型のサービス業であり、多くの専門家が関与しています。眼科医師、看護師、技術者などさまざまな職種が協力して患者の視覚健康を支えています。したがって、機器や医薬品の進化は、単に技術的な進歩だけでなく、教育やトレーニングの重要性も再認識させるものです。 眼科用機器や医薬品の選択は、患者の病歴や生活スタイルを考慮した上で、専門医の診断と判断に基づいて行われます。患者とのコミュニケーションも非常に重要であり、治療方法や使用方法についてしっかりと説明し、納得して治療を受けてもらうことが求められます。特に高齢者に対しては、視覚の重要性を考慮し、生活の質を維持するための適切な選択を行うことが不可欠です。 最後に、眼科用機器及び医薬品の進展は、視覚障害を持つ多くの人々に新たな希望をもたらすものです。これらの技術や治療法が普及することで、より多くの人々が健康な視力を取り戻し、生活の質を向上させることができるようになることが期待されています。視覚は人間にとって非常に重要な感覚であり、その健康を守るために眼科医療は今後も不断の努力を続けていく必要があるでしょう。 |
